| Alzheimer Disease |
1 |
1 |
| Washington |
0 |
0.59 |
| Biomarker |
0 |
0.4 |
| Geriatrics |
0 |
0.4 |
| Cognitive Impairment |
0 |
0.28 |
| Amyloid-Beta |
0 |
0.2 |
| Dementia |
0 |
0.2 |
| Impairment |
0 |
0.2 |
| Plasma |
0 |
0.2 |
| Multiple Sclerosis |
0 |
0.17 |
| Positron Emission Tomography |
0 |
0.17 |
| Mild Cognitive Impairment |
0 |
0.12 |
| Apolipoproteins |
0 |
0.1 |
| Autopsy |
0 |
0.1 |
| Blood |
0 |
0.1 |
| Brain |
0 |
0.1 |
| Cerebrospinal Fluid |
0 |
0.1 |
| Disease-Modifying Therapy |
0 |
0.1 |
| Genetics |
0 |
0.1 |
| Glatiramer Acetate |
0 |
0.1 |
| Match |
0 |
0.1 |
| Missouri |
0 |
0.1 |
| Myelin |
0 |
0.1 |
| Tissue |
0 |
0.1 |
| Biologic Therapy |
0 |
0.06 |
| Cardiovascular Risk Management |
0 |
0.06 |
| Genomic Medicine |
0 |
0.06 |
| Lipids Management |
0 |
0.06 |
| Medical Life |
0 |
0.06 |